Visit My Account to manage your email alerts.
Low-dose Photofrin-induced PDT offers excellent clinical response with minimal morbidity in chest wall recurrence of breast cancer
Preliminary clinical data on a new photodynamic therapy photosensitizer: 2-[1-hexyloxyethyl]-2-devinylpyropheophorbide-a (HPPH) for treatment of obstructive esophageal cancer
Photofrin mediated PDT in normal rat brain: assessment on apoptosis as a quantitative biological endpoint
Comparison of PDT efficiencies for photo-oxidation of substrate (NADPH) using a photosensitizer (Photofrin II)
First experience of photodithazine clinical application for photodynamic therapy of malignant tumors